Evidence map›Paper›PMID 25672420›Full record

ArticleEpidemiology and infection2015

High prevalence of hepatitis C (HCV) in the emergency department (ED) of a London hospital: should we be screening for HCV in ED attendees?

C Orkin, E Leach, S Flanagan, E Wallis, M Ruf, G R Foster, C Y W Tong

Open access · bronzeAbstract read
In one paragraph

Article in Epidemiology and infection, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
1.3field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 27 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. [In-hospital process for viral hepatitis C screening and management in China (Draft)].Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology · 2021
    Article
  7. Article
  8. [Establishment and implementation of hepatitis C screening and referral channels in the hospitals].Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology · 2020
    Article
  9. Article
  10. Article
  11. Hepatitis C Virus Screening of High-Risk Patients in a Canadian Emergency Department.Canadian journal of gastroenterology & hepatology · 2020
    Observational
  12. Article
  13. Article
  14. Article
  15. Article
  16. Evaluation of a strategy for identification of hepatitis C virus carriers in outpatient and emergency units: contribution to the microelimination of hepatitis C in Brazil.The Brazilian journal of infectious diseases : an official publication of the Brazilian Society of Infectious Diseases
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

C OrkinDepartment of Infection and Immunology,The Royal London Hospital,Barts Health NHS Trust,London,UK.
E LeachDepartment of Biochemistry,The Royal London Hospital,Barts Health NHS Trust,London,UK.
S FlanaganDepartment of Infection and Immunology,The Royal London Hospital,Barts Health NHS Trust,London,UK.
E WallisDepartment of Infection and Immunology,The Royal London Hospital,Barts Health NHS Trust,London,UK.
M RufDepartment of Medical Affairs,Gilead Sciences Ltd,Uxbridge,Middlesex,UK.
G R FosterBlizard Institute of Cell and Molecular Science, Queen Mary University London,London,UK.
C Y W TongDepartment of Virology,The Royal London Hospital,Barts Health NHS Trust,London,UK.
Royal London Hospital · GBGilead Sciences (United Kingdom) · GBQueen Mary University of London · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

An unlinked anonymous study was conducted to estimate the prevalence of hepatitis C virus (HCV) infection in emergency department (ED) attendees at a London Hospital. Nine hundred and ninety-seven samples collected over a 12-day period were tested for HCV antibody (Ab) and reactive samples were further tested for HCV RNA. The HCV seroprevalence was 2·6% (26/997) with 1·2% (12/997) HCV RNA positive. A peak HCV RNA-positive prevalence of 4·8% (3/63) was found in males aged 35-44 years, this was compared to 0% (0/136) in males aged <35 years (P = 0·0614) and 1·4% (4/278) in males aged ⩾45 years (P = 0·2415). Assuming the cost for HCV Ab is £6 and HCV RNA is £40 per test, screening ED attendees aged 25-54 years would cost £360 per viraemic infection and identify 82% of those who were HCV RNA positive, yielding the most favourable cost/benefit ratio. HCV screening of ED attendees aged 25-54 years in this population could be an effective way of identifying patients and limit onward transmission.

Indexed as

Emergency Service, HospitalAdultFemaleHepatitis CHepatitis C AntibodiesHumansLondonMaleMass ScreeningMiddle AgedPrevalenceRNA, ViralHepatitis C AntibodiesRNA, ViralEmergency departmentHCV RNA-positive prevalencehepatitis Cscreeningseroprevalence

Identifiers

PMID25672420
PMCPMC9151058
OpenAlexW2163123056

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.